NGM Biopharmaceuticals is a biopharmaceutical company involved in the discovery and development of medicines for various diseases. The company focuses on creating biologic drug candidates to address medical needs and advancing them through clinical trials. NGM Biopharmaceuticals' research and development efforts are directed towards generating medicines that target various market indications. It was founded in 2008 and is based in South San Francisco, California.

Dialectica offers Neural Stem Cell-based Systems and Assays for drug screening in neurodegenerative diseases. The mission of Dialectica is to add value to the link between research and pharmaceutical and biotechnology companies that are active in the discovery of therapeutics for brain diseases. Dialectica develops and optimize Neural Stem Cell-based Systems and Assays for drug screening in neurodegenerative diseases.

LeukoSight is a biopharmaceutical company focused on developing anti-inflammatory therapeutics for autoimmune and inflammatory diseases. Their main offerings include reprogramming white blood cells to produce immunoregulatory molecules. LeukoSight's initial targets are conditions like multiple sclerosis. It is based in Columbia, Maryland.

is a contract research organization that collaborates with R&D departments of biotechnology and biopharmaceutical companies to discover and develop new medicines. The company also engages in its own drug discovery agenda to develop treatments of treat tropical diseases such as malaria.

Osprey Pharmaceuticals is a privately held biotechnology company focused on developing and commercializing a first-in-class family of therapeutic proteins (Leukocyte Population Modulators) capable of treating chronic diseases. Osprey's broad technology platform is based on the critical insight that many common diseases are propagated by overabundant and overactive leukocytes. The company's proprietary LPMs selectively and systematically destroy disease-related leukocytes by infiltrating the chemokine system that regulates the movement and activity of leukocytes.

Limerick BioPharma is a biotechnology company that develops drugs within the pharmaceutical industry. The company creates compounds designed to minimize toxic side effects on non-targeted organs and tissues, while maintaining or improving the effectiveness of drugs. Limerick BioPharma's offerings include compounds for treating metabolic diseases like hypercholesteremia and hyperglycemia. It was founded in 2004 and is based in South San Francisco, California.